IL6 and rheumatoid arthritis: (114), the inhibitory effects of five JAK inhibitors—including tofacitinib, baricitinib, peficitinib, upadacitinib, and filgotinib—were compared with respect to interleukin (IL)-6-induced inflammation in rheumatoid arthritis (RA) synovial tissues.